SCHEMBL30830730

SCHEMBL30830730

CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccc(C(=O)N3CCC4(CC3)CCN(c3ccc(OC5CCC(=O)NC5=O)cn3)CC4)cc2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 10/20 0.47
▸ BRD9 Q9H8M2 3/20 0.47
▸ BRD1 O95696 1/20 0.47
▸ ACHE P22303 1/20 0.47
▸ BRPF1 P55201 1/20 0.47
▸ BPTF Q12830 1/20 0.47
▸ KAT2A Q92830 1/20 0.47
▸ BRD7 Q9NPI1 1/20 0.47
▸ BAZ2B Q9UIF8 1/20 0.47
▸ BRPF3 Q9ULD4 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.36
▸ HPGD P15428 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ DDB1 Q16531 3/20 0.34
▸ CRBN Q96SW2 3/20 0.34
▸ ADRA1A P35348 1/20 0.32
▸ CYP3A4 P08684 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830481 0.93 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830504 0.92 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831097 0.90 KAT2B (0.49) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830641 0.88 KAT2B (0.53) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830661 0.86 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830656 0.85 KAT2B (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830944 0.85 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830603 0.85 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830728 0.85 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30831002 0.85 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback